Safety and Immunogenicity of a Personalized Polyepitope DNA Vaccine Strategy in Breast Cancer Patients With Persistent Triple-Negative Disease Following Neoadjuvant Chemotherapy
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer|Triple-Negative Breast Cancer|Triple Negative Breast Neoplasms
Interventions: BIOLOGICAL: Personalized polyepitope DNA vaccine
Sponsor: Washington University School of Medicine
Collaborators: Susan G. Komen Breast Cancer Foundation